All In MedTech

Device Trial Radar · NCT00578994

A Clinical Investigation of the Oxford® Meniscal Unicompartmental Knee System

A Prospective, Non-randomized, Multicenter Study of the Oxford® Meniscal Unicompartmental Knee System

Last checked: Nov 20, 2026Latest source record: Apr 21, 2021 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

388

Actual

Start

Mar 2006

Primary completion

Dec 31, 2019

Study completion Mar 31, 2021

Sponsor

Lead sponsor
Biomet Orthopedics, LLCPublic (ZBH)
Sponsor type
Industry
First posted
Dec 21, 2007

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to collect information on complications and survivorship of patients implanted with the Oxford™ Meniscal Unicompartmental Knee System at multiple sites in the United States.

Conditions

  • Osteoarthritis
  • Avascular Necrosis

Interventions

  • Oxford® Meniscal Unicompartmental Knee SystemDevice

    Oxford® Meniscal Unicompartmental Knee System is a medial, unicompartmental knee prosthesis containing three components: a femoral component, a tibial component, and a tibial meniscal bearing.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. SurvivorshipTime frame: Annually for 9 years post-op

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Barrington Orthopedic Specialissts

    Schaumburg, Illinois

  • Joint Implant Surgeons

    New Albany, Ohio

  • Mid-South Orthopedic Associates

    Cordova, Tennessee

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.